LEVETIRACETAM DEXCEL 250

Šalis: Izraelis

kalba: anglų

Šaltinis: Ministry of Health

Veiklioji medžiaga:

LEVETIRACETAM

Prieinama:

DEXCEL PHARMA TECHNOLOGIES LTD

ATC kodas:

N03AX14

Vaisto forma:

TABLETS

Sudėtis:

LEVETIRACETAM 250 MG

Vartojimo būdas:

PER OS

Recepto tipas:

Required

Pagaminta:

DEXCEL LTD, ISRAEL

Farmakoterapinė grupė:

LEVETIRACETAM

Gydymo sritis:

LEVETIRACETAM

Terapinės indikacijos:

Levetiracetam Dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.Levetiracetam Dexcel is indicated as adjunctive therapy:• In the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.• In the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.

Leidimo data:

2018-03-31